FI943422A - Förfarande för bestämning av precursorer för cytolytiska T-celler - Google Patents

Förfarande för bestämning av precursorer för cytolytiska T-celler Download PDF

Info

Publication number
FI943422A
FI943422A FI943422A FI943422A FI943422A FI 943422 A FI943422 A FI 943422A FI 943422 A FI943422 A FI 943422A FI 943422 A FI943422 A FI 943422A FI 943422 A FI943422 A FI 943422A
Authority
FI
Finland
Prior art keywords
cytolytic
precursors
cells
determining
determining precursors
Prior art date
Application number
FI943422A
Other languages
English (en)
Finnish (fi)
Other versions
FI943422A0 (sv
Inventor
Pierre G Coulie
Thierry Boon-Falleur
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of FI943422A0 publication Critical patent/FI943422A0/sv
Publication of FI943422A publication Critical patent/FI943422A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI943422A 1992-01-21 1994-07-19 Förfarande för bestämning av precursorer för cytolytiska T-celler FI943422A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82393392A 1992-01-21 1992-01-21
PCT/US1993/000083 WO1993014189A1 (en) 1992-01-21 1993-01-07 Method for determining cytolytic t cell precursors

Publications (2)

Publication Number Publication Date
FI943422A0 FI943422A0 (sv) 1994-07-19
FI943422A true FI943422A (sv) 1994-07-19

Family

ID=25240169

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943422A FI943422A (sv) 1992-01-21 1994-07-19 Förfarande för bestämning av precursorer för cytolytiska T-celler

Country Status (8)

Country Link
EP (1) EP0624189A4 (sv)
JP (1) JPH07503134A (sv)
KR (1) KR950700402A (sv)
AU (1) AU3435293A (sv)
CA (1) CA2128424A1 (sv)
FI (1) FI943422A (sv)
NO (1) NO942660L (sv)
WO (1) WO1993014189A1 (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ242875A (en) * 1991-05-23 1993-09-27 Ludwig Inst Cancer Res Tumour rejection antigens (tra's); tumour rejection antigen precursors (trap's); their uses and properties
US6280962B1 (en) 1991-11-25 2001-08-28 Yoreh Biotechnologies Ltd. Whole blood/mitogen assay for the early detection of a subject with cancer and kit
US6322989B1 (en) 1991-11-25 2001-11-27 Yoreh Biotechnologies, Ltd. Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit
US6352826B1 (en) 1991-11-25 2002-03-05 Yoreh Biotechnologies, Ltd. Method and kit for the detection of retroviral specific antibodies in seronegative individuals
US5874560A (en) 1994-04-22 1999-02-23 The United States Of America As Represented By The Department Of Health And Human Services Melanoma antigens and their use in diagnostic and therapeutic methods
CA2188432C (en) 1994-04-22 2011-02-01 Yutaka Kawakami Melanoma antigens
US5843648A (en) * 1995-01-10 1998-12-01 The United States Of America As Represented By The Secretary, Department Of Health And Human Services P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
US6951917B1 (en) 1995-09-26 2005-10-04 The United States Of America As Represented By The Department Of Health And Human Services MHC-class II restricted melanoma antigens and their use in therapeutic methods
US7501501B2 (en) 1995-09-26 2009-03-10 The United States Of America As Represented By The Secretary Department Of Health And Human Services MHC-Class II restricted melanoma antigens and their use in therapeutic methods
EP0879282B1 (en) * 1996-01-17 2003-07-02 Imperial College Innovations Limited Immunotherapy using cytotoxic t lymphocytes (ctl)
US20040156861A1 (en) 1996-07-11 2004-08-12 Figdor Carl Gustav Melanoma associated peptide analogues and vaccines against melanoma
AU5066098A (en) * 1996-11-22 1998-06-10 Shiloov Medical Technologies Ltd. A whole blood/mitogen assay for the early detection of a subject with cancer and kit

Also Published As

Publication number Publication date
EP0624189A4 (en) 1995-05-17
WO1993014189A1 (en) 1993-07-22
FI943422A0 (sv) 1994-07-19
AU3435293A (en) 1993-08-03
NO942660D0 (no) 1994-07-15
JPH07503134A (ja) 1995-04-06
CA2128424A1 (en) 1993-07-22
EP0624189A1 (en) 1994-11-17
KR950700402A (ko) 1995-01-16
NO942660L (no) 1994-09-16

Similar Documents

Publication Publication Date Title
DE69115991D1 (de) Förderbandsystem
FI923931A (fi) Anordning foer granskning av insidan av en foergrenad roerlinje
FI945742A0 (sv) Stöd för systemutveckling
DE69125510D1 (de) Offline Schnittsysteme
FI945610A (sv) Anordning för framställning av tunnfilmer
FI933268A0 (fi) System foer bestrykning av papper och kartong
DE69308230D1 (de) Fördersystem
FI943422A (sv) Förfarande för bestämning av precursorer för cytolytiska T-celler
FI933800A0 (fi) Klammer foer sammanbindande av kantprofiler foer skaolningsplattor
FI931121A (fi) Bockningspress foer framstaellning av boejda glasrutor
ITUD920118A0 (it) Gruppo avvolgitore-svolgitore per bramme sottili
NO176415C (no) Lyslist for nivåglass
FI904845A0 (sv) Avbildningsförfarande för bestämning av strukturen av kroppar
FI945946A (sv) Förfarande för avlägsnande av fosfor
ITMI930193A0 (it) Sincronizzatore per innesti
FI923866A (fi) Foerfarande foer framstaellning av 1-hydroxialkyl-1-nitro-5 imidazoler
FI930710A (fi) Anordning foer oevervakning av vaetskenivao
ITBZ910005A1 (it) Impianto per rivestimenti con polveri
FI943660A (sv) Framställningsförfarande för 3-karbonylandrostadien-17-karboxamider
FI921817A (fi) Foerfarande och system foer aotergivning av audiofrekvenser
FI951441A (sv) Förfarande för framställning av 5-formylamino-pyrimidiner
FI953181A (sv) Förfarande för framställning av puriner
FI923005A0 (sv) Stöd för rör
FI950381A (sv) Förfarande för förestring
DE59307840D1 (de) Phosphinigsäure-arylester

Legal Events

Date Code Title Description
FD Application lapsed